|
|
Blood, 15 March 2007, Vol. 109, No. 6, pp. 2553-2556.
Prepublished online as a Blood First Edition Paper on November 7, 2006; DOI 10.1182/blood-2006-07-037960.
 Previous Article | Next Article 
Submitted July 27, 2006
Accepted October 30, 2006
Impaired Toll-like receptor 8-mediated IL-6 and TNF production in antigen presenting cells from patients with X-linked agammaglobulinaemia
Klara Sochorova, Rudolf Horvath, Daniela Rozkova, Jiri Litzman, Jirina Bartunkova, Anna Sediva, and Radek Spisek*
Institute of Immunology, Charles University, 2nd Medical School, Prague, Czech Republic.
Department of Clinical Immunology and Allergology, Masaryk University, Brno, Czech Republic
* Corresponding author; email: rspisek{at}rockefeller.edu.
The critical role of Bruton's tyrosine kinase (Btk) in B-cells has been documented by the block of B-cell development in X-linked agammaglobulinemia (XLA). Less is known about Btk function in myeloid cells. Several pieces of evidence indicate that Btk is a component of Toll-like receptors (TLRs) signaling. We analyzed whether Btk deficiency in XLA is associated with an impaired dendritic cells (DCs) compartment or defective TLR signaling. We analyzed the expression of TLRs 1-9 on myeloid DCs generated from XLA patients, and evaluated their response to activation by specific TLRs agonists. We show that XLA patients have normal numbers of circulating DCs. Btk deficient DCs have no defect in response to stimulation of TLRs 1/2, 2/6, 3, 4 and 5, but display a profound impairment of IL-6 and TNF- production in response to stimulation by TLR-8 cognate agonist, ssRNA. These findings may provide an explanation for the susceptibility to enteroviral infections in XLA patients.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Bruton tyrosine kinase (Btk): key for signaling via Toll-like receptor 8
- Ofer Levy
Blood 2007 109: 2273-2274.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
B. Morales-Aza, S. J. Glennie, T. P. Garcez, V. Davenport, S. L. Johnston, N. A. Williams, and R. S. Heyderman
Impaired maintenance of naturally acquired T-cell memory to the meningococcus in patients with B-cell immunodeficiency
Blood,
April 30, 2009;
113(18):
4206 - 4212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast
Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
J. Immunol.,
March 1, 2009;
182(5):
2919 - 2928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-G. Lee, S. Xu, E.-T. Wong, V. Tergaonkar, and K.-P. Lam
Bruton's Tyrosine Kinase Separately Regulates NF{kappa}B p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells
J. Biol. Chem.,
April 25, 2008;
283(17):
11189 - 11198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Marafioti, J. C. Paterson, E. Ballabio, K. K. Reichard, S. Tedoldi, K. Hollowood, M. Dictor, M.-L. Hansmann, S. A. Pileri, M. J. Dyer, et al.
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Blood,
April 1, 2008;
111(7):
3778 - 3792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Palmer, B. E. Mutch, S. Workman, J. P. McDaid, N. J. Horwood, and B. M. J. Foxwell
Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF{kappa}B activity
Blood,
February 15, 2008;
111(4):
1781 - 1788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Doyle, C. A. Jefferies, C. Feighery, and L. A. J. O'Neill
Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase
J. Biol. Chem.,
December 21, 2007;
282(51):
36953 - 36960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
